V
Power Law company profile
Vividion Therapeutics
Biotech & Life Sciences · San Diego, United States · Founded 2014 Unicorn
Global footprint
Where Vividion Therapeutics has talent and traffic
AI talent share
0.8%
of workforce is AI talent
(2 of 263 staff)
(2 of 263 staff)
Core AI10.38%
Other AI10.38%
Non-AI workforce26199.24%
Web traffic by country
8.1K
monthly visits
across markets
across markets
🇺🇸 United States80.2%
🇮🇳 India14.8%
🇯🇵 Japan6.2%
Patent intelligence
$1M patent portfolio · 19 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$1M
0.07% of valuation · 24.1× smaller than top peer Kymera Therapeutics ($26M)
19 active patent families
Where Vividion Therapeutics innovates
BiochemistryMolecular biologyCarcinosisCancer researchCell biology
Below peer median on Legal, Market
Quality vs same-sector peers
Vividion Therapeutics on the five Patsnap quality dimensions
Vividion Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Vividion Therapeutics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Vividion Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Vividion Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.